Press releases and news
2022
Camurus announces that Braeburn resubmits NDA for Brixadi™ in the US
Camurus to present at Jefferies 2022 Healthcare Conference London
Camurus’ Interim Report Third Quarter 2022
Camurus supports two Global Awareness Days for rare diseases
Camurus’ Nomination Committee appointed for the Annual General Meeting 2023
Camurus presenting five-year vision for growth and financial outlook at Capital Markets and R&D Day
Update of change in number of shares and votes in Camurus
Change in number of shares and votes in Camurus
Camurus supports International Overdose Awareness Day 2022
Program for Camurus’ Capital Markets and R&D Day 6 September 2022
Exercise of Camurus’ subscription warrant program 2019/2022
Camurus’ Interim Report Second Quarter 2022
Solasia acquires episil oral liquid business from Camurus
Change in number of shares and votes in Camurus
Camurus appoints Jonas Duborn as Head of Compliance
Invitation to Camurus’ Capital Markets and R&D Day 6 September 2022
Camurus to present at Jefferies 2022 Healthcare Conference New York
Change in number of shares and votes in Camurus
Resolutions at the annual general meeting 2022 in Camurus
Camurus' Interim Report January-March 2022
Get the latest news from Camurus
Subscribe to receive latest news from Camurus directly to your email.